Iterum hit by failure of anti-infective sulopenem
The company is now mulling over its future, which might include sale of the business, restructure, or dissolving and liquidating assets
Read More
Tag: anti-infective
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
